Angelor
Venture capital · France · Europe
Angelor is an independent French asset management company and société à mission approved by the AMF. It finances and supports French health innovation scaleups with capital, business expertise and a community of investors and entrepreneur mentors.
Invests inIndustrial & ManufacturingHealthcare & BiotechFood & Agriculture
In its own wordshealthcarehealthtechlife sciencesfrancescaleups
Your fit with Angelor
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAngelor lists 7 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Industrial & Manufacturing (30%), Healthcare & Biotech (30%) and Food & Agriculture (20%). 100% of its companies are based in France. It invests most often alongside IndieBio, Noshaq and SOSV.
Counts come from funding rounds that name Angelor, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 12th | 7 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 85th | 14% of companies confirmed by a round |
| Sector focus | 52th | 30% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| IndieBio | 2 |
| Noshaq | 2 |
| SOSV | 2 |
| Astanor | 1 |
| Axeleo Capital | 1 |
| Big Idea Ventures | 1 |
| Boundary Holding | 1 |
| Creative Destruction Lab | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers7100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Industrial & Manufacturing | 30% | 7% |
| Healthcare & Biotech | 30% | 15% |
| Food & Agriculture | 20% | 3% |
| Climate & Energy | 10% | 1% |
| Space & Defense | 10% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Angelor head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Angelor| Date | Company | Stage |
|---|---|---|
| 20 Jul 2026 | Series A | |
| 4 Feb 2026 | Series A |
Round details for Angelor
Amounts, full round histories and every co-investor in Angelor's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
7 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Agri Lab Leverage develops a process to transform vegetable co-products into biosourced ingredients for the food industry. | Food & Agriculture | Portfolio page | ||
| The company develops and implements a low-carbon olefins production technology using electrically activated conversion technology. | Industrial & ManufacturingClimate & Energy | Feb 2026Series A | Page + round | |
| Brenus Pharma develops off-the-shelf immunotherapies for solid tumors | Healthcare & Biotech | Jul 2026Series A | Funding round | |
| CellQuest provides solutions for the industrialization of biotherapies | Healthcare & Biotech | Portfolio page | ||
| Japet Medical designs, manufactures, and integrates exoskeletons for various industries and individuals to improve working conditions and reduce physical strain. | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Pili produces biosourced colorants and pigments as alternatives to petroleum-based products for industrial applications | Industrial & ManufacturingSpace & Defense | Portfolio page | ||
| The company produces non-animal proteins through precision fermentation, such as casein, a key protein in milk. | Food & Agriculture | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- angelor.fr
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 4 Feb 2026
- Companies checked
- 7
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Angelor's profile as data
Pull Angelor's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/angelor.fr
# also
GET /v1/firms/angelor.fr/portfolio
GET /v1/firms/angelor.fr/coinvestors
GET /v1/firms/angelor.fr/news